Atlas

Form 483

Biomedical Research Foundation of Northwest Louisiana Form 483, 2013-05-16

FDA issued a Form 483 to Biomedical Research Foundation of Northwest Louisiana on 2013-05-16 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Biomedical Research Foundation of Northwest Louisiana · Shreveport, United States · Issued May 16, 2013

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 May 2013
21 CFR 212.20(e)

Written QA procedures established, followed

Cited by Francis A Guidry

16 May 2013
21 CFR 212.50(d)

Records of checks made

Cited by Francis A Guidry

Inspected site

BRBiomedical Research Foundation of Northwest LouisianaShreveport, United States

Inspection team

FAFrancis A Guidry

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.20(e)Cited across public-safe Form 483 observations1x
21 CFR 212.50(d)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Book a demoStart a free trial

Full 483 report

Get the verbatim text of all 2 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere